KRISTEN MARTINEZ: Open Payments
NPI 1225495914 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,940 in 116 payments from 18 companies in 2025. Trend: 2023 $536 · 2024 $2,901 · 2025 $2,940
Food & beverage: $2,740Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $521 |
| UCB, Inc. | 10 | $345 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $330 |
| Regeneron Healthcare Solutions, Inc. | 10 | $328 |
| E.R. Squibb & Sons, L.L.C. | 14 | $304 |
| Janssen Biotech, Inc. | 13 | $292 |
| Novartis Pharmaceuticals Corporation | 11 | $268 |
| GENZYME CORPORATION | 4 | $96 |
| Arcutis Biotherapeutics, Inc. | 3 | $81 |
| Lilly USA, LLC | 4 | $80 |
Products named: DUPIXENT, Bimzelx, ILUMYA, Sotyktu, TREMFYA, SKYRIZI, RINVOQ, COSENTYX.
Industry payments across TX — which companies pay providers there.
